Sunscreen TEAs Could Illuminate How Deadlines Influence FDA’s Process
This article was originally published in The Pink Sheet Daily
CHPA says FDA’s work on sunscreen TEAs under deadlines already set will give an idea of the impact from changes Congress imposed for FDA’s TEA process. But the industry will not know whether the changes benefit introducing other new OTC ingredients until FDA establishes and follows process deadlines.
You may also be interested in...
FDA has heard from some manufacturers that additional time is needed to meet all of the requirements, “especially during the COVID-19 pandemic.” Prior to the pandemic, agency announced enforcement discretion during 2020 for compliance by firms with more than $10m in annual sales.
ODS Director Steven Tave says violative manufacturing processes and products remain common not because FDA isn’t enforcing its regulations. “I applaud those who stand behind their products, but can you stand with the same conviction behind every product on the market?” he said at regulatory summit organized by trade groups.
"Because of what a lot of consumers are facing right now, layoffs, furloughs, working online, they may not be aware of how this health savings account benefit can serve them at this time,” says Finance Bar CEO Marsha Barnes. CHPA is preparing digital campaign to explain that health savings, flexible spending and similar pre-tax accounts once again can be used for direct purchases of OTC drugs.